Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma
Letter 2016 en
Authors
PB
Piers Blombery
ET
Ella R. Thompson
KJ
Kate Jones
Abstract
1 min read
Systemic anaplastic large cell lymphoma (sALCL) is an aggressive T-cell non Hodgkin lymphoma which is divided into two categories based on the expression of the anaplastic lymphoma kinase (ALK) protein (i.e. ALK-positive ALCL and ALK-negative ALCL). ALK-negative sALCL typically presents with
AH Sarris, R. Luthra, V. Papadimitracopoulou, M. Waasdorp, Meletios A Dimopoulos, J. A. McBride, Fernando Cabanillas, Madeleine Duvic, AB Deisseroth, SW Morris, WC Pugh
AH Sarris, R. Luthra, V. Papadimitracopoulou, M. Waasdorp, Meletios A Dimopoulos, J. A. McBride, Fernando Cabanillas, Madeleine Duvic, AB Deisseroth, SW Morris, WC Pugh
Tongzhang Zheng, Stephen J. Chanock, Nathaniel Rothman, Brenda M. Birmann, James R. Cerhan, Sonja I. Berndt, Amy Moore, Eleanor Kane, Lauren R. Teras, Mitchell J. Machiela, Joshua Arias, Orestis A. Panagiotou, Alain Monnereau, Nicole Wong Doo, Zhaoming Wang, Susan L. Slager, Roel Vermeulen, Claire M. Vajdic, Karin E. Smedby, John J. Spinelli, Joseph Vijai, Graham G. Giles, Brian K. Link,
Discussion(0)
No comments yet. Be the first to comment.